Harbour Investments, Inc. Aptevo Therapeutics Inc. Transaction History

Harbour Investments, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.26 - $6.3 $407 - $787	125 New	125 $0
Q4 2021 Feb 16, 2022	SELL	$6.48 - $17.49 $0 - $0	0 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.01 - $22.16 $0 - $0	0 New	0 $0

Ticker APVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,090,640
Market Cap $24.5M
Description
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.